CA ATC N06DA02 · updated 2 Nov 2026
Donepezil shortage in Canada
Is there a Donepezil shortage in Canada?
Yes. As of 2 Nov 2026, 13 Donepezil products are reported short in Canada, the first since 28 Nov 2018. The company estimate for the return is 18 Dec 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Belgium, Czechia, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | SEPTA DONEPEZIL (30s Pack) | SEPTA PHARMACEUTICALS INC | 28 Nov 2018 | not given | Other Other (Please describe in comments) |
| CA | SEPTA DONEPEZIL (30s and 100s) | SEPTA PHARMACEUTICALS INC | 21 May 2020 | not given | Other Other (Please describe in comments) |
| CA | SEPTA DONEPEZIL (30s and 100s) | SEPTA PHARMACEUTICALS INC | 21 May 2020 | not given | Other Other (Please describe in comments) |
| CA | DONEPEZIL (100) | LABORATOIRE RIVA INC. | 12 Jan 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | NAT-DONEPEZIL (100 BLS) | NATCO PHARMA (CANADA) INC | 13 Jun 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NAT-DONEPEZIL (100 BTL) | NATCO PHARMA (CANADA) INC | 13 Jun 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DONEPEZIL (100) | TEVA CANADA LIMITED | 30 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DONEPEZIL (100 & 30) | TEVA CANADA LIMITED | 5 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NAT-DONEPEZIL (100 BTL) | NATCO PHARMA (CANADA) INC | 21 Apr 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DONEPEZIL (100 BTL) limited | APOTEX INC | 6 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-DONEPEZIL (100) | ACCORD HEALTHCARE INC | 5 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DONEPEZIL (100 BTL) | APOTEX INC | 18 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ARICEPT (Btl 1x30) | PFIZER CANADA ULC | 21 Apr 2026 | 18 Dec 2026 | Manufacturing problem Requirements related to complying with good manufacturing practices |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.